These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20943626)

  • 1. What can the pathologist offer for optimal treatment choice?
    Viale G; Mastropasqua MG
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii27-9. PubMed ID: 20943626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neoadjuvant treatment of breast cancer: implications for the pathologist].
    Le Guellec S; Perallon R; Alunni JP; Charitansky H; Leaha C; Gonzalez AM; Chateau MC; Simony-Lafontaine J; Jacot W; Gutowski M; Penault-Llorca F; Dalenc F; Lacroix-Triki M
    Ann Pathol; 2011 Dec; 31(6):442-54. PubMed ID: 22172117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Survey of Breast Pathologists' Practice in Staging Multiple Foci of Invasive Carcinoma.
    Wu JM; Turashvili G
    Clin Breast Cancer; 2021 Oct; 21(5):e506-e511. PubMed ID: 33386230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and behavior of small breast carcinomas.
    Meyer JS; Fahrner M; Daniel FC
    Semin Diagn Pathol; 1999 Aug; 16(3):257-68. PubMed ID: 10490202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking TNM: breast cancer TNM classification for treatment decision-making and research.
    Veronesi U; Viale G; Rotmensz N; Goldhirsch A
    Breast; 2006 Feb; 15(1):3-8. PubMed ID: 16473737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast cancer classification is evolving].
    Penault-Llorca F
    Biol Aujourdhui; 2014; 208(4):251-9. PubMed ID: 25840451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-phase study model for the standardization of HER2 immunohistochemical assay on invasive ductal carcinoma of the breast.
    Sampatanukul P; Chaiwun B; Wongwaisayawan S; Suwanagool P; Vinyuvat S; Karalak A; Praditphol N; Paueksakon P; Ruangvejvorachai P; Field AS; Wannakrairot P
    J Med Assoc Thai; 2005 Nov; 88(11):1680-8. PubMed ID: 16471119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentameric last-digit preference and stage border avoidance in pathology measurement.
    den Bakker MA; Damhuis RAM
    Histopathology; 2018 Sep; 73(3):510-513. PubMed ID: 29701881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologist's health-care value in the triage of Oncotype DX
    Dabbs DJ; Clark BZ; Serdy K; Onisko A; Brufsky AM; Smalley S; Perkins S; Bhargava R
    Histopathology; 2018 Oct; 73(4):692-700. PubMed ID: 29920746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Special clinical and follow-up aspects of invasive lobular breast cancer].
    Mitze M; Meyer F; Goepel E; Kleinkauf-Houcken A; Jonat W
    Geburtshilfe Frauenheilkd; 1991 Dec; 51(12):973-9. PubMed ID: 1794684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEOM clinical guidelines for the treatment of metastatic breast cancer.
    Alvarez López I; de la Haba Rodríguez J; Ruiz Simón A; Bellet Ezquerra M; Calvo Martínez L; García Estévez L; Rodríguez Lescure Á; Isla Casado D;
    Clin Transl Oncol; 2010 Nov; 12(11):719-23. PubMed ID: 20974562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive diagnosis in breast cancer - Whats new in 2018?].
    Ryška A
    Cesk Patol; 2018; 54(1):13-16. PubMed ID: 29631406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
    Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
    Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of breast cancer: new recommended standard procedure.
    Ravaioli A; Pasini G; Polselli A; Papi M; Tassinari D; Arcangeli V; Milandri C; Amadori D; Bravi M; Rossi D; Fattori PP; Pasquini E; Panzini I
    Breast Cancer Res Treat; 2002 Mar; 72(1):53-60. PubMed ID: 12000220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological work up of the primary tumor: getting the proper information out of it.
    Viale G
    Breast; 2011 Oct; 20 Suppl 3():S82-6. PubMed ID: 22015299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory carcinomas of the breast.
    Anderson JM
    Ann R Coll Surg Engl; 1980 May; 62(3):195-9. PubMed ID: 7396347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer under age 40: a different approach.
    Ribnikar D; Ribeiro JM; Pinto D; Sousa B; Pinto AC; Gomes E; Moser EC; Cardoso MJ; Cardoso F
    Curr Treat Options Oncol; 2015 Apr; 16(4):16. PubMed ID: 25796377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.